PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30581726-3	2019	The disease was controlled with rituximab, cyclophosphamide, oncovin, and prednisolone (i.e., R-COP) chemotherapy.	Prednisolone	74-86	caspase recruitment domain family member 16	Homo sapiens	96-99	
26725355-4	2015	Because of the patient"s age, he was administered a regimen of cyclophosphamide, pirarubicin, vincristine, and prednisolone (THP-COP), and achieved a partial response after six courses.	Prednisolone	111-123	caspase recruitment domain family member 16	Homo sapiens	129-132	
28666424-8	2017	Significant improvement was noticed after three cycles of chemotherapy of THP-COP (pirarubicin, cyclophosphamide, vincristine, and prednisolone).	Prednisolone	131-143	caspase recruitment domain family member 16	Homo sapiens	78-81	
24393897-8	2013	The patient was hospitalized to receive pirarubicin hydrochloride, cyclophosphamide, vincristine sulfate, and prednisolone (THP-COP) therapy.	Prednisolone	110-122	caspase recruitment domain family member 16	Homo sapiens	128-131	
22790134-3	2012	After 6 cycles of rituximab, cyclophosphamide, vincristine and prednisolone (R-COP) therapy, his renal function improved enough to discontinue hemodialysis.	Prednisolone	63-75	caspase recruitment domain family member 16	Homo sapiens	79-82	
24171046-6	2013	The patient received six cycles of chemotherapy with a combination of cyclophosphamide, vincristine, and prednisolone (COP regimen).	Prednisolone	105-117	caspase recruitment domain family member 16	Homo sapiens	119-122	
11450997-8	2001	Chemotherapy was utilized with cyclophosphamide, vincristine and prednisolone (COP) initially for four courses and followed by adding doxorubicin (CHOP) for another three courses.	Prednisolone	65-77	caspase recruitment domain family member 16	Homo sapiens	79-82	
21438831-2	2011	We previously described the benefit of the THP-COP regimen comprising cyclophosphamide, THP, vincristine, and prednisolone for elderly patients with diffuse large B-cell lymphoma (DLBCL).	Prednisolone	110-122	caspase recruitment domain family member 16	Homo sapiens	47-50	
15005346-0	2004	Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.	Prednisolone	78-90	caspase recruitment domain family member 16	Homo sapiens	97-100	
9364867-6	1997	Chemotherapy with pirarubicin, cyclophosphamide, vincristin, and prednisolone (THP-COP) was not effective for his lymphoma.	Prednisolone	65-77	caspase recruitment domain family member 16	Homo sapiens	83-86	
1433946-0	1992	[Effective treatment of CMMoL with F-COP (epirubicine, cyclophosphamide, vincristine, prednisolone) therapy].	Prednisolone	86-98	caspase recruitment domain family member 16	Homo sapiens	37-40	
1433946-7	1992	Treatment with F-COP (epirubicine, cyclophosphamide, vincristine, prednisolone) therapy, resulted in a dramatic improvement of her condition.	Prednisolone	66-78	caspase recruitment domain family member 16	Homo sapiens	17-20